product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
beta-Defensin 3 Antibody - BSA Free
catalog :
NB200-117
quantity :
0.1 ml (also 0.025 ml)
price :
409 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
C7
reactivity :
human
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 25
Reference |
---|
Sato M, Miyoshi K, Nakamura S, Ohtsuka M, Sakurai T, Watanabe S, et al. Efficient Generation of Somatic Cell Nuclear Transfer-Competent Porcine Cells with Mutated Alleles at Multiple Target Loci by Using CRISPR/Cas9 Combined with Targeted Toxin-Based Selection System. Int J Mol Sci. 2017;18: pubmed publisher
|
Jeong K, Kim H. Neonatal capsaicin treatment in rats induces chronic hyperthermia resulting in infectious disease. Exp Ther Med. 2015;10:2417-2423 pubmed
|
Nguyen A, Hirama T, Chauhan V, MacKenzie R, Milne R. Binding characteristics of a panel of monoclonal antibodies against the ligand binding domain of the human LDLr. J Lipid Res. 2006;47:1399-405 pubmed
|
Maxwell K, Fisher E, Breslow J. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci U S A. 2005;102:2069-74 pubmed
|
Gillian Daniel D, Bates P, Tebon A, Attie A. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A. 2002;99:4337-42 pubmed
|
Jaworska Wilczyńska M, Wilczynski G, Engel W, Strickland D, Weisgraber K, Askanas V. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle. Neurology. 2002;58:438-45 pubmed
|
Jørgensen M, Jensen O, Holst H, Hansen J, Corydon T, Bross P, et al. Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum. J Biol Chem. 2000;275:33861-8 pubmed
|
product information
brand :
Novus Biologicals, a Bio-Techne brand
catalog number base :
NB200-117
SKU :
NB200-117
product name :
beta-Defensin 3 Antibody - BSA Free
description :
The beta-Defensin 3 Antibody - BSA Free from Novus Biologicals is a rabbit polyclonal antibody to beta-Defensin 3. This antibody reacts with human,rat. The beta-Defensin 3 Antibody - BSA Free has been validated for the following applications: ELISA,Immunohistochemistry,IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Immunocytochemistry/ Immunofluorescence.
target :
beta-Defensin 3
unit size :
0.1 ml (also 0.025 ml)
category :
Primary Antibodies
buffer :
PBS
clonality :
Polyclonal
concentration :
1 mg/ml
conjugate :
Unconjugated
host :
Rabbit
immunogen :
A synthetic peptide made to an internal portion of Defensin beta 3 (between amino acids 10-60) [UniProt P81534]
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human,Rat
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
theoretical molecular weight :
7.7 kDa
gene symbol :
DEFB103B
accessionNumbers :
P81534
applications :
ELISA,Immunohistochemistry,IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Immunocytochemistry/ Immunofluorescence
USD :
399
USD 2025 :
409 USD
alt names :
BD3, BD-3, beta-defensin 103, Beta-defensin 3, DEFB103, DEFB-3, DEFB3DEFB103A, Defensin, beta 103, defensin, beta 103B, Defensin-like protein, hBD-3, HBD3HBP3
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
browse more products
questions and comments